Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.3 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.5 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.6 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.2 BC Cancer Agency KEL Library | Available | ||
c.7 BC Cancer Agency KEL Cancer Info Ctr | On Loan, due Wednesday, May 29, 2024 |
Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP publication 98. Ann ICRP> 2005; 35(3) : iii-vi, 3-50. Review Erratum in: Ann ICRP 2005; 35(4) :141.
"This poster presents the target organs for all agents classified as carcinogenic to humans (Group 1) by the IARC Monographs Programme (in red), and for the interventions showing sufficient evidence of a cancer-preventive effect in the IARC Handbooks of Cancer Prevention (in green)."
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 24 February - 3 March, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |